Celldex Therapeutics reported $0 in Loan Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US $ 33291M 4833M
Applied Genetic Technologies AGTC:US $ 15.66M 2.07M
Aptinyx Inc APTX:US $ 14.04M 14.04M
Arena Pharmaceuticals ARNA:US $ 37.48M 1.3M
Biocept BIOC:US $ 1.63M 0M
Bristol Myers Squibb BMY:US $ 39677M 2826M
Celldex Therapeutics CLDX:US $ 0M 0M
Glaxosmithkline GSK:US $ 20736M 294M
Merrimack Pharmaceuticals MACK:US $ 0 0
Nektar Therapeutics NKTR:US $ 0M 0M
Newlink Genetics NLNK:US $ 0M 0M
Northwest Biotherapeutics NWBO:US 12.34M 53K
Rigel Pharmaceuticals RIGL:US $ 19.89M 0.03M
Seattle Genetics SGEN:US $ 0M 0M